SS Innovations International, Inc.

SS Innovations International, Inc. is a commercial-stage surgical robotics company that designs, manufactures, and markets the SSi Mantra Surgical Robotic System. This system is intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. The company aims to make advanced surgical robotics technologies more accessible globally, particularly in underserved regions, as access has historically been limited to developed countries like the U.S., the EU, and Japan. Development of the SSi Mantra began in 2014. The SSi Mantra received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) in India and commercially launched sales in late 2022. The company also received ISO 13485 (quality management system) approval for the SSi Mantra in November 2021. The latest generation, SSi Mantra 3, was introduced in India with telesurgery and tele-proctoring capabilities and advanced energy instrumentation. The SSi Mantra 3 received CDSCO approval in November 2024 and has been clinically validated for safety, efficacy, and effectiveness for its intended use in robotically assisted surgeries.